Hayden Becker and his family distributed hundreds of BRCA mutation test kits to members of Park Avenue Synagogue. This article was produced as part of the New York Jewish Week’s Teen Journalism ...
An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...
Every time Ni'Kesia publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...
On Tuesday, 23andMe announced it will start telling customers of its mail-in DNA-testing kit about three mutations in the breast-cancer genes BRCA1 and BRCA2—a move officially sanctioned by the Food ...
It might feel like your world stops after receiving a diagnosis of breast or ovarian cancer. Even in that mental and emotional fog, there are several next steps to consider. Coming up with a treatment ...
The familial BRCA mutation alone does not put a relative at greater risk. Oct. 31, 2011— -- Women whose female relatives have a notorious breast cancer gene but who do not have the gene ...
April 16, 2008 — Women who carry the BRCA gene mutation have an estimated 85% lifetime risk of developing breast cancer, but a prophylactic mastectomy reduces this risk to less than 1%, Dutch ...
The possibility of carrying the BRCA gene mutation can be concerning to women who've been diagnosed with cancer especially when their children may eventually be affected. The phone rang. It was my ...
7don MSN
Why prostate cancer is expected to be left as the only major cancer without national screening
Prostate cancer is expected to remain the only major cancer not to have a national screening programme under new ...
Three studies examine how resistance to chemotherapy develops in cancers deficient in BRCA1 and BRCA2. The mechanism involves restoration of BRCA1 and BRCA2 activity. Shah examines the implications ...
In this interview, Mark Robson, Chief of the Breast Medicine Service at Memorial Sloan Kettering, discusses olaparib, the latest drug approved for breast cancer, and how genetic testing can lead to ...
We tend to think of BRCA genetic mutations as a major risk for breast cancer—and they are. But these mutations—present on genes that can normally help suppress tumor activity via producing proteins ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback